Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 31, 2025
Spatial
metabolomics
is
an
emerging
technology
that
integrates
mass
spectrometry
imaging
(MSI)
with
metabolomics,
offering
a
novel
visual
perspective
for
traditional
analysis.
This
enables
in-depth
analysis
in
three
dimensions:
qualitative,
quantitative,
and
localization
of
metabolites.
precisely
reflects
the
characteristics
metabolic
network
changes
metabolites
within
entire
tissues
or
specific
micro-regions.
It
provides
detailed
understanding
pharmacodynamic
material
basis
mechanisms
action.
These
capabilities
suggest
spatial
can
offer
significant
technical
support
studying
complex
pathophysiology
mental
disorders.
Although
underlying
disorders
have
been
reviewed
multiple
times,
this
paper
comprehensive
comparison
between
metabolomics.
also
summarizes
latest
progress
challenges
applying
to
study
Chinese
medicine.
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 9, 2024
Diabetic
peripheral
neuropathy
(DPN)
refers
to
the
development
of
nerve
dysfunction
in
patients
with
diabetes
when
other
causes
are
excluded.
distal
symmetric
polyneuropathy
(DSPN)
is
most
representative
form
DPN.
As
one
common
complications
diabetes,
its
prevalence
increases
duration
diabetes.
10-15%
newly
diagnosed
T2DM
have
DSPN,
and
can
exceed
50%
for
more
than
10
years.
Bilateral
limb
pain,
numbness,
paresthesia
clinical
manifestations
DPN,
severe
cases,
foot
ulcers
occur,
even
leading
amputation.
The
etiology
pathogenesis
diabetic
not
yet
completely
clarified,
but
hyperglycemia,
disorders
lipid
metabolism,
abnormalities
insulin
signaling
pathways
currently
considered
be
initiating
factors
a
range
pathophysiological
changes
In
presence
abnormal
metabolic
factors,
normal
structure
function
entire
nervous
system
disrupted,
including
myelinated
unmyelinated
axons,
perikaryon,
neurovascular,
glial
cells.
addition,
pathway
will
inhibit
neural
axon
repair
promote
apoptosis
damaged
Here,
we
discuss
recent
advances
study
DPN
mechanisms,
oxidative
stress
pathways,
mechanisms
microvascular
damage,
damage
receptor
potential
associated
neuroinflammation,
mitochondrial
dysfunction,
cellular
damage.
Identifying
contributions
from
each
associations
between
them
may
help
us
further
explore
targeted
screening
treatment
interventions.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(15), P. 12378 - 12378
Published: Aug. 3, 2023
Diabetes
mellitus
(DM)
belongs
to
the
category
of
socially
significant
diseases
with
epidemic
rates
increases
in
prevalence.
Diabetic
nephropathy
(DN)
is
a
specific
kind
kidney
damage
that
occurs
40%
patients
DM
and
considered
serious
complication
DM.
Most
modern
methods
for
treatments
aimed
at
slowing
down
progression
DN
have
side
effects
do
not
produce
unambiguous
positive
results
long
term.
This
fact
has
encouraged
researchers
search
additional
or
alternative
treatment
methods.
Hyperglycemia
negative
effect
on
renal
structures
due
number
factors,
including
activation
polyol
hexosamine
glucose
metabolism
pathways,
renin-angiotensin-aldosterone
sympathetic
nervous
systems,
accumulation
advanced
glycation
end
products
insulin
resistance
endothelial
dysfunction
tissues.
The
above
mechanisms
cause
development
oxidative
stress
(OS)
reactions
mitochondrial
dysfunction,
which
turn
contribute
DN.
Modern
antioxidant
therapies
involve
various
phytochemicals
(food
antioxidants,
resveratrol,
curcumin,
alpha-lipoic
acid
preparations,
etc.),
are
widely
used
only
diabetes
but
also
other
systemic
diseases.
It
been
suggested
therapeutic
approaches
target
source
reactive
oxygen
species
may
certain
advantages
terms
nephroprotection
from
OS.
review
describes
significance
studies
OS
biomarkers
pathogenesis
analyzes
reducing
intensity
prevention
Cell Death and Disease,
Journal Year:
2024,
Volume and Issue:
15(6)
Published: June 24, 2024
Abstract
Diabetic
kidney
disease,
known
as
a
glomerular
arises
from
metabolic
disorder
impairing
renal
cell
function.
Mitochondria,
crucial
organelles,
play
key
role
in
substance
metabolism
via
oxidative
phosphorylation
to
generate
ATP.
Cells
undergo
reprogramming
compensatory
mechanism
fulfill
energy
needs
for
survival
and
growth,
attracting
scholarly
attention
recent
years.
Studies
indicate
that
mitochondrial
significantly
influences
the
pathophysiological
progression
of
DKD.
Alterations
lead
abnormal
expression
signaling
molecules
activation
pathways,
inducing
stress-related
cellular
damage,
inflammatory
responses,
apoptosis,
autophagy
irregularities,
culminating
fibrosis
insufficiency.
This
review
delves
into
impact
on
DKD
pathogenesis,
emphasizing
regulation
regulators
downstream
pathways.
Therapeutic
interventions
targeting
can
potentially
delay
progression.
The
findings
underscore
importance
focusing
develop
safer
more
effective
therapeutic
approaches.
Archives of Physiology and Biochemistry,
Journal Year:
2023,
Volume and Issue:
130(6), P. 616 - 641
Published: Aug. 11, 2023
Diabetes
mellitus
(DM)
is
a
huge
global
health
issue
and
one
of
the
most
studied
diseases,
with
large
prevalence.
Oxidative
stress
cytotoxic
consequence
excessive
development
ROS
suppression
antioxidant
defense
system
for
elimination,
which
accelerates
progression
diabetes
complications
such
as
diabetic
neuropathy,
retinopathy,
nephropathy.
Hyperglycaemia
induced
oxidative
causes
activation
seven
major
pathways
implicated
in
pathogenesis
complications.
These
increase
production
RNS,
contributes
to
dysregulated
autophagy,
gene
expression
changes,
numerous
pro-inflammatory
mediators
may
eventually
lead
This
review
will
illustrate
that
plays
vital
role
complications,
use
antioxidants
help
reduce
thus
alleviate
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(1), P. 137 - 137
Published: Jan. 22, 2024
Kidney
fibrosis,
diffused
into
the
interstitium,
vessels,
and
glomerulus,
is
main
pathologic
feature
associated
with
loss
of
renal
function
chronic
kidney
disease
(CKD).
Fibrosis
may
be
triggered
in
diseases
by
different
genetic
molecular
insults.
However,
several
studies
have
shown
that
fibrosis
can
linked
to
oxidative
stress
mitochondrial
dysfunction
CKD.
In
this
review,
we
will
focus
on
three
pathways
link
namely:
(i)
hyperglycemia
energy
imbalance,
(ii)
mineralocorticoid
signaling
pathway,
(iii)
hypoxia-inducible
factor
(HIF)
pathway.
We
selected
these
because
they
are
targeted
available
medications
capable
reducing
such
as
sodium-glucose
cotransporter-2
(SGLT2)
inhibitors,
non-steroidal
receptor
antagonists
(MRAs),
HIF-1alpha-prolyl
hydroxylase
inhibitors.
These
drugs
a
reduction
reduced
collagen
deposition
across
CKD
subtypes.
there
still
long
winding
road
clear
understanding
anti-fibrotic
effects
compounds
humans,
due
inherent
practical
ethical
difficulties
obtaining
sequential
biopsies
lack
specific
biomarkers
measurable
easily
accessible
matrices
like
urine.
narrative
describe
pathways,
their
interconnections,
activity
fibrosis.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 8, 2024
Rhodiola
rosea
is
a
valuable
functional
medicinal
plant
widely
utilized
in
China
and
other
Asian
countries
for
its
anti-fatigue,
anti-aging,
altitude
sickness
prevention
properties.
Salidroside,
most
active
constituent
derived
from
,
exhibits
potent
antioxidative,
hypoxia-resistant,
anti-inflammatory,
anticancer,
anti-aging
effects
that
have
garnered
significant
attention.
The
appreciation
of
the
pharmacological
role
salidroside
has
burgeoned
over
last
decade,
making
it
beneficial
option
treatment
multiple
diseases,
including
atherosclerosis,
Alzheimer’s
disease,
Parkinson’s
cardiovascular
more.
With
renoprotective
effects,
parallel
with
inhibition
oxidative
stress
inflammation,
holds
promise
as
potential
therapeutic
agent
kidney
damage.
This
article
provides
an
overview
microinflammatory
state
disease
discuss
current
strategies,
particular
focus
on
highlighting
recent
advancements
utilizing
renal
disease.
mechanisms
action
are
primarily
associated
regulation
gene
protein
expression
glomerular
endothelial
cells,
podocytes,
tubule
mesangial
cells
cell
carcinoma
cell,
TNF-α,
TGF-β,
IL-1β,
IL-17A,
IL-6,
MCP-1,
Bcl-2,
VEGF,
ECM
protein,
caspase-3,
HIF-1α,
BIM,
well
modulation
AMPK/SIRT1,
Nrf2/HO-1,
Sirt1/PGC-1α,
ROS/Src/Cav-1,
Akt/GSK-3β,
TXNIP-NLRP3,
ERK1/2,
TGF-β1/Smad2/3,
PI3K/Akt,
Wnt1/Wnt3a
β-catenin,
TLR4/NF-κB,
MAPK,
JAK2/STAT3,
SIRT1/Nrf2
pathways.
To
best
our
knowledge,
this
review
first
to
comprehensively
cover
protective
diverse
suggests
great
be
developed
drug
metabolic
syndrome,
cerebrovascular
diseases
complications.
Aggregate,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 6, 2024
Abstract
Diabetes
significantly
impairs
the
body's
wound‐healing
capabilities,
leading
to
chronic,
infection‐prone
wounds.
These
wounds
are
characterized
by
hyperglycemia,
inflammation,
hypoxia,
variable
pH
levels,
increased
matrix
metalloproteinase
activity,
oxidative
stress,
and
bacterial
colonization.
complex
conditions
complicate
effective
wound
management,
prompting
development
of
advanced
diabetic
care
strategies
that
exploit
specific
characteristics
such
as
acidic
pH,
high
glucose
stress
trigger
controlled
drug
release,
thereby
enhancing
therapeutic
effects
dressings.
Among
solutions,
hydrogels
emerge
promising
due
their
stimuli‐responsive
nature,
making
them
highly
for
managing
these
The
latest
advancements
in
mono/multi‐stimuli‐responsive
smart
showcase
superiority
potential
healthcare
materials,
highlighted
relevant
case
studies.
However,
traditional
dressings
fall
short
meeting
nuanced
needs
wounds,
adjustable
adhesion,
easy
removal,
real‐time
status
monitoring,
dynamic
release
adjustment
according
wound's
conditions.
Responsive
represent
a
significant
leap
forward
proficient
sensing
responding
environment,
offering
more
targeted
approach
treatment.
This
review
highlights
recent
dressing,
delivery,
emphasizing
role
improving
healing.
It
addresses
ongoing
challenges
future
directions,
aiming
guide
clinical
adoption.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 2, 2025
Chronic
hyperglycemia,
a
hallmark
of
diabetes,
can
trigger
inflammatory
responses
in
the
kidney,
leading
to
diabetic
nephropathy
(DN).
Follistatin-like
protein
1
(FSTL1)
has
emerged
as
potential
therapeutic
target
various
kidney
diseases.
This
study
investigated
effect
high
glucose
on
FSTL1
expression
and
its
role
oxidative
stress
cellular
transdifferentiation
injury
HK-2
human
proximal
tubule
epithelial
cells,
model
DN.
We
FSTL1's
level
cells
exposed
using
Western
blotting
quantitative
real-time
polymerase
chain
reaction
(qRT-PCR).
was
manipulated
recombinant
(rhFSTL1)
or
lentiviral
shFSTL1.
then
analyzed
proliferation,
stress,
transdifferentiation,
cell
migration,
nuclear
factor
kappa-B
(NF-κB)
signaling
pathway
potentially
involved
effects.
Finally,
we
blocked
NF-κB
see
influence
these
processes.
High
exposure
significantly
increased
with
longer/higher
further
amplifying
this
effect.
Silencing
ameliorates
damage
by
promoting
enhancing
superoxide
dismutase
(SOD)
glutathione
(GSH)
activity,
reducing
malondialdehyde
(MDA)
production,
inhibiting
migration.
Furthermore,
it
prevented
harmful
conversion
from
myofibroblast-like
phenotypes,
evidenced
decreased
fibronectin
(FN)
α-smooth
muscle
actin
(α-SMA)
preserved
E-cadherin.
Notably,
silencing
also
inhibited
pathway.
Conversely,
rhFSTL1
exhibited
opposite
Importantly,
blocking
reversed
detrimental
effects
FSTL1.
These
findings
suggest
that
contributes
glucose-induced
via
Targeting
may
represent
novel
strategy
for
preventing
mitigating
DN
progression.